Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
11 April 2016 - P1343
Ceftobiprole resistance in Danish MRSA
Anders Rhod Larsen, Stainton Sean, Larsen Anders Rhod, A. Larsen, A. Petersen, F. Hansen, A. Santerre Henriksen, R. Skov
11 April 2016 - P1344
New drugs active against both rifampin- and methicillin-resistant Staphylococcus aureus (MRSA) isolates from an Italian surveillance study
Floriana Campanile, Campanile Floriana, Mendes Rodrigo E., F. Campanile, D. Bongiorno, S. Benvenuto, V. Cafiso, M. Santagati, S. Stefani
11 April 2016 - P1345
Comparison of MRSA susceptibility to ceftobiprole as determined by either Etest or microdilution methods
Annarita Mazzariol, Lepore Antonio, Mazzariol Annarita, L. Galia, G. Cornaglia, A. Mazzariol
11 April 2016 - P1346
In vitro activity of vancomycin and ceftaroline against various clones of methicillin-resistant Staphylococcus aureus (MRSA) isolates from a tertiary hospital in AU
Shradha Subedi, Subedi Shradha, Lepore Antonio, S. Subedi, C. Finemore, M. O'Sullivan, F. Zhou, R. Balgahom, J. Branley M
11 April 2016 - P1347
Comparative activities of ceftaroline and ceftriaxone against bacterial pathogens associated with community-associated respiratory infections
Daniel Sahm, Lepore Antonio, Sahm Daniel, D. Biedenbach, J. Iaconis, D. Sahm
11 April 2016 - P1348
Activity of ceftaroline tested against Staphylococcus collected from a nationwide study in Spain in 2014
Petra Camernik, Cercenado Emilia, Lepore Antonio, E. Cercenado, C. Oscar, A. Vindel, F. Román Alonso, M. Marín, E. Bouza Santiago, S. Study Group
11 April 2016 - P1349
Characterization of MRSA-resistance to ceftaroline, responsible for skin and soft tissue infections in PL 2010-2013
Dinesh Aggarwal, Lepore Antonio, Zabicka Dorota, K. Bojarska, D. Zabicka, M. Herda, W. Hryniewicz
11 April 2016 - P1350
In Vitro antimicrobial activity of ceftaroline against coagulase-negative staphylococci: global report from the assessing worldwide antimicrobial resistance evaluation (AWARE) 2012-2014 programme
Daniel Sahm, Sahm Daniel, Bhagwat Sachin, D. Biedenbach, J. Iaconis, D. Sahm
11 April 2016 - P1351
In vitro activity of tedizolid and key comparators against Staphylococcus aureus isolated from Latin America: 2014-2015
Daniel Sahm, Huband Michael, Sahm Daniel, D. Biedenbach, M. Hackel, T. Lynch, J. Alder, D. Sahm
11 April 2016 - P1352
Activity of tedizolid tested against Staphylococcus collected from a nationwide study in Spain in 2014
Petra Camernik, Cercenado Emilia, Cammarata Sue, E. Cercenado, C. Oscar, M. Marín, F. Román Alonso, A. Vindel, M. Bensaci, E. Bouza Santiago, S. Study Group
11 April 2016 - P1353
The activity of tedizolid against Gram-positive pathogens isolated from patients in European and ILi medical Centres: 2014 surveillance
David Farrell, Cammarata Sue, Farrell David, D. Farrell, H. Sader, R. Mendes, R. Jones
11 April 2016 - P1354
Tidezolid versus glycopeptide combination therapies for the treatment of multidrug-resistant Staphylococcus aureus infections
Jonathan Betts, Betts Jonathan, Cammarata Sue, D. Wareham, L. Phee, H. Fikry
11 April 2016 - P1355
Activity of linezolid when tested against contemporary European bacterial clinical isolates (2015)
Robert Flamm, R. Flamm, R. Mendes, J. Streit, H. Sader, P. Hogan, R. Jones
11 April 2016 - P1356
Analysis of the activity of telavancin tested against a global collection of Staphylococcus aureus clinical isolates responsible for documented hospital-acquired pneumonia (2014)
Rodrigo E. Mendes, Mendes Rodrigo E., R. Mendes, R. Flamm, H. Sader, J. Smart, D. Farrell, R. Jones
11 April 2016 - P1357
Oritavancin activity tested against European staphylococcal clinical isolates and resistant subsets including those with reduced susceptibility to daptomycin, teicoplanin or vancomycin (2010 – 2014)
Rodrigo E. Mendes, Croisier Delphine, Mendes Rodrigo E., R. Mendes, H. Sader, R. Flamm, D. Farrell, R. Jones
11 April 2016 - P1358
Phenotypic characterization and clinical impact of staphylococci with reduced vancomycin susceptibility isolated from clinical and surveillance samples in a large tertiary care teaching hospital, Southern India
Rajesh Amberpet, Amberpet Rajesh, Sahm Daniel, R. Amberpet, S. Sistla, S. Parija
11 April 2016 - P1359
Antimicrobial susceptibility patterns of Gram-positive pathogens collected from European countries
Meredith Hackel, Critchley Ian A., Hackel Meredith, D. Biedenbach, D. Sahm, M. Hackel, H. Leister-Tebbe
11 April 2016 - P1360
In vitro activity of tigecycline against commonly isolated pathogens of skin and skin structure infections (SSSI) in Spain
Daniel Sahm, Sahm Daniel, Mermer Sinan, B. Johnson, D. Biedenbach, D. Sahm, M. Hackel, H. Leister-Tebbe
11 April 2016 - P1361
Antimicrobial susceptibility of Enterococcus spp. isolated from blood in haematological patients: results of multicenter study in Russia
Galina Klyasova, Mercer Derry, Fedorova (Mironova) Anastasia, A. Fedorova (Mironova), G. Klyasova, S. Khrulnova, I. Frolova, M. Maschan, N. Yuritcina, S. Vereschagina, L. Krainova, T. Pospelova, I. Molchanova, O. Kutsevalova, O. Khoreva, R. Khokhlyavina, N. Zvezdkina
Loading ...
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.